In this issue of Heart Failure Clinics, guest editors Drs. Vijay Rao and Geetha Bhatt bring their considerable expertise to the topic of Novel Non-pharmacological Approaches to Heart Failure. Recent years have seen a multitude of new devices and non-pharmacologic approaches to heart failure (HF), which, in the properly selected patient, can have significant impacts on morbidity and mortality. This issue provides a contemporary summary of these innovative approaches from leaders in the field. - Contains 14 relevant, practice-oriented topics including barostimulation in HF; remote monitoring devices in HF; HIS bundle pacing in HF; A.fib ablation and HF (CASTLE-AF) and beyond; interatrial shunt devices; stem cell therapy in HF; novel approaches to sleep apnea in HF; and more. - Provides in-depth clinical reviews on novel non-pharmacological approaches to heart failure, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This issue of Heart Failure Clinics examines the pharmacologic approaches to heart failure: optimizing established therapy with a look toward future agents. Topics include the pathophysiologic foundation for the pharmacologic treatment of heart failure, treatment of heart failure with reducted ejection fraction and preserved ejection fraction, treatment of acute heart failure, investigational treatments, and the role of congestive heart failure medications following left ventricular assist device.

This book offers essential guidance on the diagnosis, management and treatment of heart failure using the latest Ventricular Assist Devices and approaches such as Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Non-invasive Positive Pressure Ventilation, Intra-Aortic Balloon Pumping, Extra Corporeal Membrane Oxygenation and so on. It provides practical guidelines on the monitoring using those devices, as well as techniques and treatment strategies, and features two dedicated chapters on heart transplants and regenerative therapy. The main content is complemented by a wealth of full-color figures and diagrams to clearly demonstrate the operative techniques and tools discussed. Given its scope, Update on Non-pharmacological Therapy for Heart Failure offers a valuable resource, not only for cardiologists and cardiac surgeons, but also for clinical residents and medical students.

Recent advances have changed the way heart failure is treated and have resulted in substantial improvements in heart failure management. Improving Outcomes in Heart Failure addresses innovative ways of dealing with issues such as quality of life, treatment compliance, effective patient and family education and counseling, nonpharmacologic therapy, and new health care delivery models for improving the management of heart failure. With an interdisciplinary approach, this reference shows how heart failure outcomes and health care resource utilization can be improved significantly. Written by the editors of the distinguished Journal of Cardiovascular Nursing, Debra K. Moser, DNSc, RN and Barbara Riegel, DNSc, RN, CS, FAAN are well-known and nationally recognized experts in the field of cardiovascular nursing. Moser and Riegel have received numerous prestigious awards and honors and have contributed to many renowned journals on a wide variety of cardiovascular topics.

This book is intended to be a link between guidelines and clinical practice, a complementary tool to help physicians to be well informed regarding the important field of heart failure. It will be a useful tool for professionals from all the fields of cardiology: non-invasive cardiology, interventional cardiology, electrophysiology and cardiovascular imaging. The topic of heart failure is continuously changing, with new important information being added constantly. The pathophysiology is better understood and there is a trend for a better characterization of special groups of population, such as oncologic patients with heart failure. The new imaging techniques have become valuable tools for the diagnosis of heart failure, while pharmacological and novel cell and gene treatments have evolved enormously. The challenge for the practitioners is making the right selection of treatment strategy that best fits a patient. This book presents detailed information on the indications, selection and mechanism of action of these treatments, whether they be mechanical circulatory devices or pharmacological treatments. The contemporary pharmacological and non-pharmacological management of heart failure has the main target of early prevention of disease progression and the avoidance of heart transplant. In the era of shortage of donors, prevention is the mainstay of the therapeutic strategy, and this is the main philosophy of our book.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

In this issue of Heart Failure Clinics, guest editor Dr. Purvi Parwani brings her considerable expertise to the topic of the Changing Landscape of Heart Failure Imaging. Top experts cover the latest updates in heart failure imaging; imaging in HCM: beyond risk stratification; aortic stenosis: advanced Imaging parameters and the changing treatment landscape; mitral regurgitation: advanced Imaging parameters and the changing treatment landscape; heart failure preserved EF in women; and more. Contains 12 relevant, practice-oriented topics including artificial intelligence in heart failure imaging; ischemic cardiomyopathy: imaging-guided therapies; evaluation and management of cardiac sarcoidosis with advanced imaging; viral myocarditis and dilated cardiomyopathy: changing diagnostic insight from advanced imaging; and more. Provides in-depth clinical reviews on the changing landscape of heart failure imaging, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more. Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more. Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.